Goldman Sachs maintained a Neutral rating on Eli Lilly (NYSE: LLY) and lowered its price target to $54.00 (from $56.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE